Moderna has paid $400 million to the government for a chemical technique key to its vaccine. But the parties are still locked in a high-stakes dispute over a different patent.
Fairchain generates digital contracts and certificates of title and authenticity, allowing artists to track their work and share in secondary market proceeds.